Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

被引:146
作者
Barton, Mary B.
Petitti, Diana B. [2 ]
DeWitt, Thomas G. [3 ]
Dietrich, Allen [4 ]
Gordis, Leon [5 ]
Gregory, Kimberly D. [6 ]
Harris, Russell [7 ]
Isham, George [8 ]
LeFevre, Michael L. [9 ]
Leipzig, Rosanne [10 ]
Loveland-Cherry, Carol [11 ]
Marion, Lucy N. [12 ]
Moyer, Virginia A. [13 ]
Ockene, Judith K. [14 ]
Sawaya, George F. [15 ]
Yawn, Barbara P. [16 ]
机构
[1] Colorado Dept Publ Hlth & Environm, Denver, CO USA
[2] Arizona State Univ, Phoenix, AZ USA
[3] Childrens Hosp Med Ctr, Cincinnati, OH USA
[4] Dartmouth Med Sch, Lebanon, NH USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[6] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[7] Univ N Carolina, Sch Med, Chapel Hill, NC USA
[8] HealthPartners, Minneapolis, MN USA
[9] Univ Missouri, Sch Med, Columbia, MO USA
[10] Mt Sinai Sch Med, New York, NY USA
[11] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA
[12] Med Coll Georgia, Sch Nursing, Augusta, GA 30912 USA
[13] Baylor Coll Med, Houston, TX 77030 USA
[14] Univ Massachusetts, Sch Med, Worcester, MA USA
[15] Univ Calif San Francisco, San Francisco, CA 94143 USA
[16] Olmsted Med Ctr, Rochester, MN USA
关键词
screening; treatment; depression; child and adolescent;
D O I
10.1542/peds.2008-2381
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
DESCRIPTION. This is an update of the 2002 US Preventive Services Task Force recommendation on screening for child and adolescent major depressive disorder. METHODS. The US Preventive Services Task Force weighed the benefits and harms of screening and treatment for major depressive disorder in children and adolescents, incorporating new evidence addressing gaps in the 2002 recommendation statement. Evidence examined included the benefits and harms of screening, the accuracy of primary care-feasible screening tests, and the benefits and risks of treating depression by using psychotherapy and/or medications in patients aged 7 to 18 years. RECOMMENDATIONS. Screen adolescents (12-18 years of age) for major depressive disorder when systems are in place to ensure accurate diagnosis, psychotherapy (cognitive-behavioral or interpersonal), and follow-up (B recommendation). Evidence is insufficient to warrant a recommendation to screen children (7-11 years of age) for major depressive disorder (I statement). Pediatrics 2009; 123: 1223-1228
引用
收藏
页码:1223 / 1228
页数:6
相关论文
共 6 条
[1]   Suicidality in adolescents being treated with antidepressant medications and the black box label: Position paper of the Society for Adolescent Medicine [J].
Lock, J ;
Walker, LR ;
Rickert, VI ;
Katzman, DK .
JOURNAL OF ADOLESCENT HEALTH, 2005, 36 (01) :92-93
[2]  
MacMillan HL, 2004, SCREENING DEPRESSION
[3]  
March J, 2004, JAMA-J AM MED ASSOC, V292, P807
[4]   Age effects on antidepressant-induced manic conversion [J].
Martin, A ;
Young, C ;
Leckman, JF ;
Mukonoweshuro, C ;
Rosenheck, R ;
Leslie, D .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2004, 158 (08) :773-780
[5]  
Pignone M, 2002, SCREENING DEPRESSION
[6]   Screening for Child and Adolescent Depression in Primary Care Settings: A Systematic Evidence Review for the US Preventive Services Task Force [J].
Williams, Selvi B. ;
O'Connor, Elizabeth A. ;
Eder, Michelle ;
Whitlock, Evelyn P. .
PEDIATRICS, 2009, 123 (04) :E716-E735